8/26/2026
Americans face risks at overseas psychedelic clinics
Ibogaine treatments in Mexico raise safety concerns for U.S. patients.
Topic archive
10 stories
8/26/2026
Ibogaine treatments in Mexico raise safety concerns for U.S. patients.
8/21/2026
David Dardashti shares clinical footage as psychedelic therapy gains federal interest.
8/19/2026
Trump's administration advances psychedelic therapies for PTSD and TBI in veterans.
8/19/2026
Barrow Neurological Institute to explore ibogaine's potential for PTSD and brain injuries.
8/18/2026
Governor's order initiates ibogaine, MDMA, and psilocybin study
7/31/2026
Mississippi explores ibogaine trials for addiction treatment, reflecting a shift towards health-centered drug policies.
7/31/2026
Luttrell's IBOGAINE Act aims to solidify psychedelic therapy access for veterans.
7/23/2026
Order encourages psychedelic research, allocates $50M for state studies.
7/22/2026
Trump's 2026 executive order boosts psychedelic research funding and collaboration.
7/15/2026
New agreement includes ibogaine research for opioid use disorder.